Bronchiolitis: Difference between revisions
No edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Bronchiolitis | |||
| image = [[File:Bronchiolitis_Medical_Image.png|250px]] | |||
| caption = Chest X-ray of a child with bronchiolitis | |||
| field = [[Pulmonology]] | |||
| symptoms = [[Cough]], [[wheezing]], [[shortness of breath]], [[fever]] | |||
| complications = [[Respiratory failure]], [[dehydration]] | |||
| onset = Typically in children under 2 years old | |||
| duration = 1 to 2 weeks | |||
| causes = [[Viral infection]], most commonly [[Respiratory syncytial virus]] (RSV) | |||
| risks = [[Premature birth]], [[heart disease]], [[immunodeficiency]] | |||
| diagnosis = [[Clinical diagnosis]], [[chest X-ray]], [[nasal swab]] | |||
| differential = [[Asthma]], [[pneumonia]], [[foreign body aspiration]] | |||
| prevention = [[Hand washing]], avoiding exposure to sick individuals | |||
| treatment = [[Supportive care]], [[oxygen therapy]], [[hydration]] | |||
| medication = [[Bronchodilators]], [[corticosteroids]] (limited use) | |||
| prognosis = Generally good, but can be severe in some cases | |||
| frequency = Common in infants and young children, especially in winter months | |||
}} | |||
'''Bronchiolitis''' is inflammation of the [[bronchiole]]s, the smallest air passages of the lungs. It usually occurs in children less than two years of age with the majority being aged between three and six months. | '''Bronchiolitis''' is inflammation of the [[bronchiole]]s, the smallest air passages of the lungs. It usually occurs in children less than two years of age with the majority being aged between three and six months. | ||
[[File:Bronchiolitis chest X-ray.jpg|alt=Bronchiolitis chest X-ray|thumb|Bronchiolitis chest X-ray]] | [[File:Bronchiolitis chest X-ray.jpg|alt=Bronchiolitis chest X-ray|left|thumb|Bronchiolitis chest X-ray]] | ||
== Signs and symptoms == | == Signs and symptoms == | ||
In a typical case, an infant under two years of age develops [[cough]], [[wheeze]], and shortness of breath over one or two days. Crackles and/or wheeze are typical findings on listening to the chest with a stethoscope. The infant may be breathless for several days. After the acute illness, it is common for the airways to remain sensitive for several weeks, leading to recurrent cough and wheeze. | In a typical case, an infant under two years of age develops [[cough]], [[wheeze]], and shortness of breath over one or two days. Crackles and/or wheeze are typical findings on listening to the chest with a stethoscope. The infant may be breathless for several days. After the acute illness, it is common for the airways to remain sensitive for several weeks, leading to recurrent cough and wheeze. | ||
<youtube> | <youtube> | ||
title='''{{PAGENAME}}''' | title='''{{PAGENAME}}''' | ||
| Line 14: | Line 33: | ||
height=600 | height=600 | ||
</youtube> | </youtube> | ||
'''Some signs of severe disease include:''' | '''Some signs of severe disease include:''' | ||
* poor feeding (less than half of usual fluid intake in preceding 24 hours) | * poor feeding (less than half of usual fluid intake in preceding 24 hours) | ||
| Line 23: | Line 41: | ||
* severe chest wall recession | * severe chest wall recession | ||
* [[cyanosis]] | * [[cyanosis]] | ||
[[File:Respiratory bronchiolitis (4841793545).jpg|alt=Respiratory bronchiolitis|thumb|Respiratory bronchiolitis]] | [[File:Respiratory bronchiolitis (4841793545).jpg|alt=Respiratory bronchiolitis|left|thumb|Respiratory bronchiolitis]] | ||
== Causes == | == Causes == | ||
* The term usually refers to acute viral bronchiolitis, a common disease in infancy. | * The term usually refers to acute viral bronchiolitis, a common disease in infancy. | ||
| Line 30: | Line 48: | ||
* It causes annual outbreaks of respiratory illnesses in all age groups. | * It causes annual outbreaks of respiratory illnesses in all age groups. | ||
* In most regions of the United States, RSV usually circulates during fall, winter, and spring, but the timing and severity of RSV season in a given community can vary from year to year. | * In most regions of the United States, RSV usually circulates during fall, winter, and spring, but the timing and severity of RSV season in a given community can vary from year to year. | ||
== Clinical Laboratory Testing == | == Clinical Laboratory Testing == | ||
* Clinical symptoms of RSV are nonspecific and can overlap with other viral respiratory infections, as well as some bacterial infections. | * Clinical symptoms of RSV are nonspecific and can overlap with other viral respiratory infections, as well as some bacterial infections. | ||
| Line 38: | Line 55: | ||
* Less commonly used tests include viral culture serology, which is usually only used for research and surveillance studies | * Less commonly used tests include viral culture serology, which is usually only used for research and surveillance studies | ||
* Some tests can differentiate between RSV subtypes (A and B), but the clinical significance of these subtypes is unclear. | * Some tests can differentiate between RSV subtypes (A and B), but the clinical significance of these subtypes is unclear. | ||
[[File:Cryptogenic organizing pneumonia (COP)-bronchiolitis obliterans (4734022020).jpg|alt=Bronchiolitis obliterans|thumb|Bronchiolitis obliterans]] | [[File:Cryptogenic organizing pneumonia (COP)-bronchiolitis obliterans (4734022020).jpg|alt=Bronchiolitis obliterans|left|thumb|Bronchiolitis obliterans]] | ||
== For Infants and Young Children == | == For Infants and Young Children == | ||
* Both rRT-PCR and antigen detection tests are effective methods for diagnosing RSV infection in infants and young children. | * Both rRT-PCR and antigen detection tests are effective methods for diagnosing RSV infection in infants and young children. | ||
* The RSV sensitivity of antigen detection tests generally ranges from 80% to 90% in this age group. | * The RSV sensitivity of antigen detection tests generally ranges from 80% to 90% in this age group. | ||
* Healthcare professionals should consult experienced laboratorians for more information on interpretation of results. | * Healthcare professionals should consult experienced laboratorians for more information on interpretation of results. | ||
== For Older Children, Adolescents, and Adults == | == For Older Children, Adolescents, and Adults == | ||
* Healthcare professionals should use highly sensitive rRT-PCR assays when testing older children and adults for RSV. | * Healthcare professionals should use highly sensitive rRT-PCR assays when testing older children and adults for RSV. | ||
| Line 50: | Line 66: | ||
* Antigen tests are not sensitive for older children and adults because they may have lower viral loads in their respiratory specimens. | * Antigen tests are not sensitive for older children and adults because they may have lower viral loads in their respiratory specimens. | ||
* Healthcare professionals should consult experienced laboratorians for more information on interpretation of results. | * Healthcare professionals should consult experienced laboratorians for more information on interpretation of results. | ||
== Prophylaxis and High-Risk Infants and Young Children == | == Prophylaxis and High-Risk Infants and Young Children == | ||
* [[Palivizumab]] is a monoclonal antibody recommended by the American Academy of Pediatrics (AAP) to be administered to high-risk infants and young children likely to benefit from [[immunoprophylaxis]] based on gestational age and certain underlying medical conditions. | * [[Palivizumab]] is a monoclonal antibody recommended by the American Academy of Pediatrics (AAP) to be administered to high-risk infants and young children likely to benefit from [[immunoprophylaxis]] based on gestational age and certain underlying medical conditions. | ||
Latest revision as of 19:06, 4 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Bronchiolitis | |
|---|---|
| File:Bronchiolitis Medical Image.png | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Cough, wheezing, shortness of breath, fever |
| Complications | Respiratory failure, dehydration |
| Onset | Typically in children under 2 years old |
| Duration | 1 to 2 weeks |
| Types | N/A |
| Causes | Viral infection, most commonly Respiratory syncytial virus (RSV) |
| Risks | Premature birth, heart disease, immunodeficiency |
| Diagnosis | Clinical diagnosis, chest X-ray, nasal swab |
| Differential diagnosis | Asthma, pneumonia, foreign body aspiration |
| Prevention | Hand washing, avoiding exposure to sick individuals |
| Treatment | Supportive care, oxygen therapy, hydration |
| Medication | Bronchodilators, corticosteroids (limited use) |
| Prognosis | Generally good, but can be severe in some cases |
| Frequency | Common in infants and young children, especially in winter months |
| Deaths | N/A |
Bronchiolitis is inflammation of the bronchioles, the smallest air passages of the lungs. It usually occurs in children less than two years of age with the majority being aged between three and six months.
Signs and symptoms[edit]
In a typical case, an infant under two years of age develops cough, wheeze, and shortness of breath over one or two days. Crackles and/or wheeze are typical findings on listening to the chest with a stethoscope. The infant may be breathless for several days. After the acute illness, it is common for the airways to remain sensitive for several weeks, leading to recurrent cough and wheeze. Some signs of severe disease include:
- poor feeding (less than half of usual fluid intake in preceding 24 hours)
- lethargy
- history of apnea
- respiratory rate >70/min
- presence of nasal flaring and/or grunting
- severe chest wall recession
- cyanosis
Causes[edit]
- The term usually refers to acute viral bronchiolitis, a common disease in infancy.
- This is most commonly caused by respiratory syncytial virus
- Respiratory syncytial virus (RSV) was discovered in 1956 and has since been recognized as one of the most common causes of childhood illness.
- It causes annual outbreaks of respiratory illnesses in all age groups.
- In most regions of the United States, RSV usually circulates during fall, winter, and spring, but the timing and severity of RSV season in a given community can vary from year to year.
Clinical Laboratory Testing[edit]
- Clinical symptoms of RSV are nonspecific and can overlap with other viral respiratory infections, as well as some bacterial infections.
- Several types of laboratory tests are available for confirming RSV infection.
- These tests may be performed on upper and lower respiratory specimens.
- The most commonly used types of RSV clinical laboratory tests are real-time reverse transcriptase-polymerase chain reaction (rRT-PCR), which is more sensitive than culture and antigen testing antigen testing, which is highly sensitive in children but not sensitive in adults
- Less commonly used tests include viral culture serology, which is usually only used for research and surveillance studies
- Some tests can differentiate between RSV subtypes (A and B), but the clinical significance of these subtypes is unclear.
For Infants and Young Children[edit]
- Both rRT-PCR and antigen detection tests are effective methods for diagnosing RSV infection in infants and young children.
- The RSV sensitivity of antigen detection tests generally ranges from 80% to 90% in this age group.
- Healthcare professionals should consult experienced laboratorians for more information on interpretation of results.
For Older Children, Adolescents, and Adults[edit]
- Healthcare professionals should use highly sensitive rRT-PCR assays when testing older children and adults for RSV.
- rRT-PCR assays are now commercially available for RSV.
- The sensitivity of these assays often exceeds the sensitivity of virus isolation and antigen detection methods.
- Antigen tests are not sensitive for older children and adults because they may have lower viral loads in their respiratory specimens.
- Healthcare professionals should consult experienced laboratorians for more information on interpretation of results.
Prophylaxis and High-Risk Infants and Young Children[edit]
- Palivizumab is a monoclonal antibody recommended by the American Academy of Pediatrics (AAP) to be administered to high-risk infants and young children likely to benefit from immunoprophylaxis based on gestational age and certain underlying medical conditions.
- It is given in monthly intramuscular injections during the RSV season, which generally occurs during fall, winter, and spring in most locations in the United States.
|
|
|
| Diseases of the respiratory system | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Common cold | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| Inflammation | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pediatric glossary of terms | Glossary of medical terms | Dictionary of pediatrics


